DIPROSONE CREAM 0.05% Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

diprosone cream 0.05%

organon belgium, belgium - betamethasone dipropionate - cream - 0.05 %

DIPROSALIC OINTMENT Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

diprosalic ointment

organon belgium, belgium - salicylic acid,betamethasone dipropionate - ointment - 30,0.5 mg/g,

LOTRIDERM CREAM Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

lotriderm cream

organon belgium - betamethasone dipropionate, clotrimazole - cream - 0.05, 1 %

DIPROSONE OINTMENT 0.05% Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

diprosone ointment 0.05%

organon belgium, belgium - betamethasone dipropionate - ointment - 0.05 %

ORADEXON ORGANON 0.05mg/ml paed.elixir Egypt - English - EDA (Egyptian Drug Authority)

oradexon organon 0.05mg/ml paed.elixir

organon-holland - syrup - 0.05 mg/ml

TETRABID ORGANON Ireland - English - HPRA (Health Products Regulatory Authority)

tetrabid organon

organon laboratories limited - tetracycline hydrochloride -

Elocon New Zealand - English - Medsafe (Medicines Safety Authority)

elocon

organon (new zealand) limited - mometasone furoate 0.1%{relative} - topical ointment - 0.1% w/w - active: mometasone furoate 0.1%{relative} excipient: hexylene glycol phosphoric acid propylene glycol monostearate purified water white beeswax white soft paraffin

Elonva New Zealand - English - Medsafe (Medicines Safety Authority)

elonva

organon (new zealand) limited - corifollitropin alfa 0.2 mg/ml;   - solution for injection - 100 mcg/0.5ml - active: corifollitropin alfa 0.2 mg/ml   excipient: hydrochloric acid methionine polysorbate 20 sodium citrate sodium hydroxide sucrose water for injection - controlled ovarian stimulation (cos) for the development of multiple follicles and pregnancy in women undergoing in-vitro fertilisation techniques.

Elonva New Zealand - English - Medsafe (Medicines Safety Authority)

elonva

organon (new zealand) limited - corifollitropin alfa 0.3 mg/ml;   - solution for injection - 150 mcg/0.5ml - active: corifollitropin alfa 0.3 mg/ml   excipient: hydrochloric acid methionine polysorbate 20 sodium citrate sodium hydroxide sucrose water for injection - controlled ovarian stimulation (cos) for the development of multiple follicles and pregnancy in women undergoing in-vitro fertilisation techniques.

Puregon New Zealand - English - Medsafe (Medicines Safety Authority)

puregon

organon (new zealand) limited - follitropin beta 833 iu/ml;   - solution for injection - 833 iu/ml - active: follitropin beta 833 iu/ml   excipient: benzyl alcohol hydrochloric acid as 0.1n solution to adjust to ph 7.0 methionine polysorbate 20 sodium citrate dihydrate sodium hydroxide as 0.1n solution to adjust to ph 7.0 sucrose water for injection - in the female: - anovulatory infertility - controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programmes [e.g. in vitro fertilisation and related procedures].